Contemporary Asymmetric Phase Transfer Catalysis: Large-Scale Industrial Applications

Asymmetric phase transfer catalysis has been recognized as an approach that is greener and more sustainable than synthetic alternatives and has evolved into one of the most practical methods in challenging enantioselective synthesis. An overview of the current status of asymmetric phase transfer catalysis in industry is presented by summarizing research progress from both journal publications and patent applications.

[1]  K. Maruoka,et al.  Enantioselective amino acid synthesis by chiral phase-transfer catalysis. , 2003, Chemical reviews.

[2]  T. Ilg,et al.  The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity. , 2014, Insect biochemistry and molecular biology.

[3]  S. Danishefsky,et al.  Eine chemische Denksportaufgabe: die Totalsynthese von Gelsemin , 2003 .

[4]  M. Mąkosza.  Phase-transfer catalysis. A general green methodology in organic synthesis , 2000 .

[5]  R. E. Conn,et al.  Chiral Michael addition: methyl vinyl ketone addition catalyzed by Cinchona alkaloid derivatives , 1986 .

[6]  Charles M. Starks,et al.  PHASE – TRANSFER CATALYSIS. I. HETEROGE NEOUS REACTIONS INVOLVING ANION TRANSFER BY QUATERNARY AMMONIUM AND PHOSPHONIUM SALTS , 1971 .

[7]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Nugent,et al.  Chiral Amine Synthesis – Recent Developments and Trends for Enamide Reduction, Reductive Amination, and Imine Reduction , 2010 .

[9]  B. Jensen.  BMS-204352: a potassium channel opener developed for the treatment of stroke. , 2006, CNS drug reviews.

[10]  Keiji Maruoka,et al.  Recent development and application of chiral phase-transfer catalysts. , 2007, Chemical reviews.

[11]  K. Maruoka,et al.  Molecular Design of a C2-Symmetric Chiral Phase-Transfer Catalyst for Practical Asymmetric Synthesis of α-Amino Acids , 1999 .

[12]  K. Scheidt,et al.  Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. , 2007, Angewandte Chemie.

[13]  P. Dalko.  Comprehensive Enantioselective Organocatalysis: Catalysts, Reactions, and Applications , 2013 .

[14]  B. Su,et al.  Concise asymmetric synthesis of a (1R,2S)-1-amino- 2-vinylcyclopropanecarboxylic acid-derived sulfonamide and ethyl ester. , 2013, Organic & biomolecular chemistry.

[15]  Bin Wang,et al.  Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease. , 2014, Journal of medicinal chemistry.

[16]  D. Enders,et al.  Asymmetric Sulfa-Michael Additions , 2007 .

[17]  R. Buchanan,et al.  Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. , 2006, Diabetes care.

[18]  R. Davies,et al.  Comparison of oral indacrinone with furosemide , 1980, Clinical pharmacology and therapeutics.

[19]  S. Reisman,et al.  Recent developments in the catalytic, asymmetric construction of pyrroloindolines bearing all-carbon quaternary stereocenters. , 2013, The Journal of organic chemistry.

[20]  E. Cragoe,et al.  (Acylaryloxy)acetic acid diuretics. 2. (2-Alkyl-2-aryl-1-oxo-5-indanyloxy)acetic acids. , 1978, Journal of medicinal chemistry.

[21]  L. Overman,et al.  Catalytic enantioselective synthesis of quaternary carbon stereocentres , 2014, Nature.

[22]  Kazuhiro Matsumoto,et al.  Asymmetric epoxidation of olefins catalyzed by Ti(salan) complexes using aqueous hydrogen peroxide as the oxidant , 2008 .

[23]  S. Saaby,et al.  Asymmetric construction of quaternary stereocenters by direct organocatalytic amination of α-substituted α-cyanoacetates and β-dicarbonyl compounds , 2004 .

[24]  E. Grabowski,et al.  Efficient catalytic asymmetric alkylations. 3. A kinetic and mechanistic study of the enantioselective phase-transfer methylation of 6,7-dichloro-5-methoxy-2-phenyl-1-indanone , 1987 .

[25]  Yian Shi,et al.  Organocatalytic oxidation. Asymmetric epoxidation of olefins catalyzed by chiral ketones and iminium salts. , 2008, Chemical reviews.

[26]  E. Grabowski,et al.  Enantioselective Robinson Annelations via Phase‐Transfer Catalysis , 1986 .

[27]  Hyeung‐geun Park,et al.  Cinchona-based phase-transfer catalysts for asymmetric synthesis. , 2009, Chemical communications.

[28]  M. O'donnell,et al.  The enantioselective synthesis of alpha-amino acids by phase-transfer catalysis with achiral Schiff base esters. , 2004, Accounts of chemical research.

[29]  Ronny Neumann,et al.  Handbook of phase transfer catalysis , 1997 .

[30]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[31]  R. Reamer,et al.  Discovery and application of doubly quaternized cinchona-alkaloid-based phase-transfer catalysts. , 2014, Angewandte Chemie.

[32]  T. Appleby,et al.  Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease. , 2012, Bioorganic & medicinal chemistry letters.

[33]  Cheng-yi Chen,et al.  Enantioselective Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Ethyl Ester (Vinyl-ACCA-OEt) by Asymmetric Phase-Transfer Catalyzed Cyclopropanation of (E)-N-Phenylmethyleneglycine Ethyl Ester , 2010 .

[34]  K. Maruoka,et al.  Recent advances in asymmetric phase-transfer catalysis. , 2007, Angewandte Chemie.

[35]  J. R. Pliego,et al.  Unraveling the Mechanism of the Cinchoninium Ion Asymmetric Phase-Transfer-Catalyzed Alkylation Reaction , 2013 .

[36]  Y. Takemoto,et al.  Chiral phosphine-free Pd-mediated asymmetric allylation of prochiral enolate with a chiral phase-transfer catalyst. , 2001, Organic letters.

[37]  K. Maruoka,et al.  Recent developments in asymmetric phase-transfer reactions. , 2013, Angewandte Chemie.

[38]  Qi Gao,et al.  The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection. , 2014, Journal of medicinal chemistry.

[39]  Renato Dalpozzo,et al.  Recent advances in organocatalytic methods for the synthesis of disubstituted 2- and 3-indolinones. , 2012, Chemical Society reviews.

[40]  Roger N. Farr,et al.  Synthesis of a selective estrogen receptor β-modulator via asymmetric phase-transfer catalysis , 2007 .

[41]  Paul N. Devine,et al.  Synthesis of vaniprevir (MK-7009): lactamization to prepare a 20-membered [corrected] macrocycle. , 2011, The Journal of organic chemistry.

[42]  M. Dobrinska,et al.  Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[43]  Michael G. Lopaze,et al.  A practical synthesis of (R)- and (S)-3-amino-3,4-dihydro-1H-quinolin-2-one , 2004 .

[44]  Abigail G Doyle,et al.  Small-molecule H-bond donors in asymmetric catalysis. , 2007, Chemical reviews.

[45]  Jeremy P. Scott,et al.  Development of a Phase Transfer Catalyzed Asymmetric Synthesis for an Estrogen Receptor Beta Selective Agonist , 2008 .

[46]  K. Maruoka.  Highly practical amino acid and alkaloid synthesis using designer chiral phase transfer catalysts as high-performance organocatalysts. , 2010, Chemical record.

[47]  Q. Xia,et al.  Advances in homogeneous and heterogeneous catalytic asymmetric epoxidation. , 2005, Chemical reviews.

[48]  J. Christoffers,et al.  Quaternary Stereocenters: Challenges and Solutions for Organic Synthesis , 2005 .

[49]  J. Vacca,et al.  Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. , 2010, ACS medicinal chemistry letters.

[50]  Takashi Ooi,et al.  Fortschritte bei asymmetrischen Phasentransferkatalysen , 2007 .

[51]  K. Prasad,et al.  A Practical Synthesis of a Chiral Analogue of FTY720 , 2008 .

[52]  J. Vacca,et al.  MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats. , 2012, Bioorganic & medicinal chemistry letters.

[53]  J. Christoffers,et al.  Construction of quaternary stereocenters: new perspectives through enantioselective Michael reactions. , 2003, Angewandte Chemie.

[54]  A. Chan,et al.  Palladium-catalyzed allylic alkylation of tert-butyl(diphenylmethylene)-glycinate with simple allyl esters under chiral phase transfer conditions , 2001 .

[55]  M. Murata,et al.  Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners. , 1998, Journal of medicinal chemistry.

[56]  M. Rudd,et al.  Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor. , 2010, Journal of medicinal chemistry.

[57]  S. Danishefsky,et al.  Gelsemine: a thought-provoking target for total synthesis. , 2003, Angewandte Chemie.

[58]  Z. Shao,et al.  Combining transition metal catalysis and organocatalysis: a broad new concept for catalysis. , 2009, Chemical Society reviews.

[59]  Karl A. Scheidt,et al.  Natürliche Pyrrolidinylspirooxindole als Vorlagen für die Entwicklung medizinischer Wirkstoffe , 2007 .

[60]  M. Fox,et al.  Dynamic kinetic resolution of dehydrocoronamic acid. , 2014, Chemical communications.

[61]  D. E. Patterson,et al.  Synthesis of 4-Fluoro-β-(4-fluorophenyl)-l-phenylalanine by an Asymmetric Phase-Transfer Catalyzed Alkylation: Synthesis on Scale and Catalyst Stability , 2007 .

[62]  D. Enders,et al.  Asymmetric organocatalytic domino reactions. , 2007, Angewandte Chemie.

[63]  J. Hummelen,et al.  Catalytic asymmetric induction in oxidation reactions. The synthesis of optically active epoxides. , 1976 .

[64]  Etsuko Tokunaga,et al.  Enantioselective synthesis of trifluoromethyl-substituted 2-isoxazolines: asymmetric hydroxylamine/enone cascade reaction. , 2010, Angewandte Chemie.

[65]  M. Rudd,et al.  Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. , 2012, ACS medicinal chemistry letters.

[66]  E. Carreira,et al.  Construction of Spiro[pyrrolidine‐3,3′‐oxindoles] − Recent Applications to the Synthesis of Oxindole Alkaloids , 2003 .

[67]  Magnus Rueping,et al.  Catalytic C-C bond-forming multi-component cascade or domino reactions: pushing the boundaries of complexity in asymmetric organocatalysis. , 2014, Chemical reviews.

[68]  M. Waser,et al.  Stereoselective cyclization reactions under phase-transfer catalysis , 2014 .

[69]  Xudong Wei,et al.  Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis. , 2006, The Journal of organic chemistry.

[70]  Martin Poirier,et al.  Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans. , 2004, Organic letters.

[71]  F. Gosselin,et al.  A practical enantioselective synthesis of odanacatib, a potent Cathepsin K inhibitor, via triflate displacement of an alpha-trifluoromethylbenzyl triflate. , 2009, The Journal of organic chemistry.

[72]  M. Warren,et al.  Hormone replacement therapy: controversies, pros and cons. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[73]  H. Zimmermann,et al.  The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase , 2011, Journal of Virology.

[74]  Barry Lygo,et al.  Asymmetric phase-transfer catalysis utilizing chiral quaternary ammonium salts: asymmetric alkylation of glycine imines. , 2004, Accounts of chemical research.

[75]  Jack Liang,et al.  Efficient, chemoenzymatic process for manufacture of the Boceprevir bicyclic [3.1.0]proline intermediate based on amine oxidase-catalyzed desymmetrization. , 2012, Journal of the American Chemical Society.

[76]  E. McGarrigle,et al.  Chromium- and manganese-salen promoted epoxidation of alkenes. , 2005, Chemical reviews.

[77]  G. Wong,et al.  Asymmetric alkylation of oxindoles: an approach to the total synthesis of (-)-physostigmine , 1991 .

[78]  Jeremy P. Scott,et al.  Enantioselective Synthesis of a Highly Substituted Tetrahydrofluorene Derivative as a Potent and Selective Estrogen Receptor Beta Agonist , 2014 .

[79]  E. Grabowski,et al.  Efficient catalytic asymmetric alkylations. 1. Enantioselective synthesis of (+)-indacrinone via chiral phase-transfer catalysis , 1984 .

[80]  H. H. Freedman.  Industrial applications of phase transfer catalysis (PTC): past, present and future , 1986 .

[81]  E. Francotte,et al.  Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer. , 2005, Journal of medicinal chemistry.

[82]  R. Stoffel,et al.  A stereoselective and scalable synthesis of a conformationally constrained S1P1 agonist , 2009 .

[83]  Martin Poirier,et al.  Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061. , 2004, Journal of medicinal chemistry.

[84]  Weiying Yang,et al.  Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: , 2006, Journal of medicinal chemistry.

[85]  J. Falgueyret,et al.  The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. , 2008, Bioorganic & medicinal chemistry letters.

[86]  J. Alemán,et al.  Applications of asymmetric organocatalysis in medicinal chemistry. , 2013, Chemical Society reviews.

[87]  G. Beutner,et al.  Development of a practical, asymmetric synthesis of the hepatitis C virus protease inhibitor MK-5172. , 2013, Organic letters.